Abstract
BackgroundPredicting which patients will respond to PD-1 blockade and identifying the relevant underlying mechanisms are major challenges in immuno-oncology. Emerging data suggest that the frequency of cancer-specific T-cells in blood...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
